Rose Geoffrey Beran — SEC insider filings
SEC reporting owner CIK 1804146. 47 insider filings on record with FilingPulse; latest filed 2026-09-03.
Transaction summary — filings shown
Covers all 47 filings on record, filed 2021-04-06 to 2026-09-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 97 legs across 43 filings — 173,581 shares, $3,634,946 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 21,640 shares @ $30.53 ($660,669) in Pulmonx Corp, filed 2021-12-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Pulmonx Corp (LUNG) | Chief Commercial Officer | 47 | — | 97 legs · 173,581 sh · $3,634,946 | 16 |
Insider filings — Rose Geoffrey Beran
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 2,213 @ $2.26 · Sale (S): 2,390 @ $2.26 · Sale (S): 1,530 @ $2.26 · Sale (S): 1,746 @ $2.26 | EDGAR |
| 2026-06-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,778 @ $1.54 · Sale (S): 1,557 @ $1.54 · Sale (S): 2,434 @ $1.54 · Sale (S): 2,254 @ $1.54 | EDGAR |
| 2026-03-04 | 4 | Pulmonx Corp (LUNG) | Sale (S): 835 @ $1.43 · Sale (S): 2,125 @ $1.43 · Sale (S): 1,861 @ $1.43 · Sale (S): 2,911 @ $1.43 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-12-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 683 @ $1.57 · Sale (S): 1,738 @ $1.57 · Sale (S): 1,522 @ $1.57 · Sale (S): 2,379 @ $1.57 | EDGAR |
| 2025-09-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 707 @ $1.60 · Sale (S): 1,799 @ $1.60 · Sale (S): 1,575 @ $1.60 · Sale (S): 2,462 @ $1.60 | EDGAR |
| 2025-06-04 | 4 | Pulmonx Corp (LUNG) | Sale (S): 401 @ $3.14 · Sale (S): 708 @ $3.13 · Sale (S): 1,799 @ $3.13 · Sale (S): 1,576 @ $3.13 · Sale (S): 2,463 @ $3.13 | EDGAR |
| 2025-03-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 520 @ $7.12 · Sale (S): 915 @ $7.12 · Sale (S): 2,327 @ $7.14 · Sale (S): 2,017 @ $7.12 · Grant/award (A): 108,000 @ $0 | EDGAR |
| 2024-12-04 | 4 | Pulmonx Corp (LUNG) | Sale (S): 392 @ $6.19 · Sale (S): 690 @ $6.18 · Sale (S): 1,756 @ $6.19 · Sale (S): 1,538 @ $6.18 | EDGAR |
| 2024-09-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 410 @ $6.71 · Sale (S): 724 @ $6.69 · Sale (S): 1,842 @ $6.69 · Sale (S): 1,610 @ $6.71 | EDGAR |
| 2024-06-26 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $6.16 | EDGAR |
| 2024-06-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 385 @ $6.97 · Sale (S): 678 @ $6.97 · Sale (S): 1,724 @ $6.97 · Sale (S): 1,510 @ $6.97 | EDGAR |
| 2024-05-23 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $8.71 | EDGAR |
| 2024-04-24 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $7.49 | EDGAR |
| 2024-03-26 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $9.36 | EDGAR |
| 2024-03-07 | 4/A | Pulmonx Corp (LUNG) | Grant/award (A): 69,100 @ $0 · Grant/award (A): 34,500 (derivative) @ $0 | EDGAR |
| 2024-03-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 428 @ $9.06 · Sale (S): 753 @ $9.06 · Sale (S): 1,916 @ $9.06 · Grant/award (A): 34,500 @ $0 · Grant/award (A): 69,100 (derivative) @ $0 | EDGAR |
| 2024-02-26 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $14.20 | EDGAR |
| 2024-01-24 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $13.13 | EDGAR |
| 2023-12-27 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $12.75 | EDGAR |
| 2023-12-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 396 @ $10.34 · Sale (S): 698 @ $10.34 · Sale (S): 1,774 @ $10.34 | EDGAR |
| 2023-11-27 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $10.60 | EDGAR |
| 2023-10-25 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $8.35 | EDGAR |
| 2023-09-26 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $10.51 | EDGAR |
| 2023-09-06 | 4 | Pulmonx Corp (LUNG) | Sale (S): 393 @ $10.01 · Sale (S): 691 @ $10.01 · Sale (S): 1,759 @ $10.01 | EDGAR |
| 2023-08-25 | 4 | Pulmonx Corp (LUNG) | Sale (S): 1,184 @ $10.54 | EDGAR |
| 2023-06-02 | 4 | Pulmonx Corp (LUNG) | Sale (S): 393 @ $11.48 · Sale (S): 692 @ $11.48 · Sale (S): 1,760 @ $11.48 | EDGAR |
| 2023-03-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 437 @ $11.03 · Sale (S): 769 @ $11.03 · Grant/award (A): 78,900 @ $0 · Grant/award (A): 54,000 (derivative) @ $0 | EDGAR |
| 2022-12-05 | 4 | Pulmonx Corp (LUNG) | Sale (S): 382 @ $5.93 · Sale (S): 673 @ $5.93 | EDGAR |
| 2022-09-06 | 4 | Pulmonx Corp (LUNG) | Sale (S): 372 @ $17.87 · Sale (S): 655 @ $17.90 | EDGAR |
| 2022-06-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 366 @ $18.05 · Sale (S): 645 @ $18.05 | EDGAR |
| 2022-03-11 | 4 | Pulmonx Corp (LUNG) | Option exercise (M): 29,427 @ $2.10 · Option exercise (M): 29,427 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 426 @ $25.91 · Grant/award (A): 31,000 @ $0 · Grant/award (A): 68,700 (derivative) @ $0 | EDGAR |
| 2021-12-16 | 4 | Pulmonx Corp (LUNG) | Sale (S): 21,640 @ $30.53 · Sale (S): 360 @ $31.48 | EDGAR |
| 2021-12-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 355 @ $32.73 | EDGAR |
| 2021-11-16 | 4 | Pulmonx Corp (LUNG) | Sale (S): 7,000 @ $39.94 | EDGAR |
| 2021-10-18 | 4 | Pulmonx Corp (LUNG) | Sale (S): 7,000 @ $39.44 | EDGAR |
| 2021-09-17 | 4 | Pulmonx Corp (LUNG) | Sale (S): 7,000 @ $38.12 | EDGAR |
| 2021-09-03 | 4 | Pulmonx Corp (LUNG) | Sale (S): 355 @ $40.09 | EDGAR |
| 2021-08-18 | 4 | Pulmonx Corp (LUNG) | Sale (S): 7,000 @ $36.71 | EDGAR |
| 2021-07-19 | 4 | Pulmonx Corp (LUNG) | Sale (S): 758 @ $37.57 · Sale (S): 6,142 @ $38.86 · Sale (S): 100 @ $39.24 | EDGAR |
| 2021-06-11 | 4 | Pulmonx Corp (LUNG) | Grant/award (A): 17,600 @ $0 · Grant/award (A): 39,900 (derivative) @ $0 | EDGAR |
| 2021-05-25 | 4 | Pulmonx Corp (LUNG) | Sale (S): 4,363 @ $40.81 · Sale (S): 24 @ $41.49 · Sale (S): 10 @ $41.52 · Sale (S): 400 @ $41.55 | EDGAR |
| 2021-05-19 | 4 | Pulmonx Corp (LUNG) | Option exercise (M): 49,428 @ $1.40 · Option exercise (M): 49,428 (derivative) @ $0 | EDGAR |
| 2021-05-11 | 4 | Pulmonx Corp (LUNG) | Sale (S): 3,778 @ $40.47 · Sale (S): 900 @ $41.47 · Sale (S): 118 @ $42.25 · Sale (S): 1 @ $42.51 | EDGAR |
| 2021-04-21 | 4 | Pulmonx Corp (LUNG) | Sale (S): 4,797 @ $43.24 | EDGAR |
| 2021-04-07 | 4/A | Pulmonx Corp (LUNG) | Sale (S): 4,478 @ $47.59 · Sale (S): 319 @ $48.43 | EDGAR |
| 2021-04-06 | 4 | Pulmonx Corp (LUNG) | Sale (S): 4,531 @ $47.59 · Sale (S): 266 @ $48.46 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-04-01 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1804146 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs